Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02604992Phase 1Completed
Phase 1, randomised, open-label trial of dronabinol in anorexia nervosa (AN), nausea ((none)) and Vomiting (6 arms), sponsored by Insys Therapeutics. Primary endpoints: Area under the curve from time 0 to the last measured concentration, Area under the curve extrapolated to infinity and 7 more. Started Nov 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02604992.